Judd Allen, MD
Orthopaedic Surgery · Saratoga Springs, UTNPI 1639463714
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,380 of the $14,128 with a category attached, or 73.5%. 9 manufacturers reported payments, led by Vericel Corporation at 54.2% of the total. 2025 is the largest year on record at $7,570, 8.1 times the $940 reported in 2019.
Across 48 payments — averaging $294.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vericel Corporation$8K
- Smith+Nephew$5K
- Active Medical, LLC$844
- Stryker$65
- Dynasplint Systems Inc.$34
- Zimmer Biomet$25
- plus $55 from 3 others
What the payments were for
- Speaking & faculty fees$10,38073%
- Travel & lodging$1,41710%
- Food & beverage$1,48711%
- Education$8446%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vericel Corporation | 27 | $7,661 |
| Smith+Nephew | 14 | $5,443 |
| Active Medical, LLC | 1 | $844 |
| Stryker | 1 | $65 |
| Dynasplint Systems Inc. | 1 | $34 |
| Zimmer Biomet | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Johnson & Johnson | 1 | $15 |
| Bioventus LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acufex$8,300
- MACI$7,153
- SPATIAL FRAME$4,150
- NOVOSTITCH$4,150
- Q-FIX$4,150
How this compares
$14,128 in reported general payments places this provider in the 70th percentile of 221 orthopaedic surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 15 | $265 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Saratoga Springs
- Hugh WestMurray$14.2M
- Aaron HofmannSalt Lake City$10.7M
- Thomas CaltonWashington Terrace$3.5M
- Jeremy GilillandSalt Lake City$2.9M
- Joshua HickmanBountiful$2.7M
- Robert TashjianSalt Lake City$2.6M
- Jeffrey JacksonSalt Lake City$2.3M
- Peter StevensSlc$2.1M
- Thomas HigginsSalt Lake City$1.2M
- Christopher MartinSalt Lake City$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.